Sio Gene Therapies
+$0.0067 (+2.30%) As of 1:17 PM UTC pre-market
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell SIOX and other ETFs, options, and stocks.
About SIOX
Sio Gene Therapies Inc. is a clinical-stage biopharmaceutical company, which engages in the acquisition, development, and commercialization of gene therapies for neurological diseases. Its product pipeline focus on Parkinson's Disease, GM1 gangliosidosis, and GM2 gangliosidosis such as Tay-Sachs disease and Sandhoff disease.
CEO
David W. Nassif
Employees
42
Headquarters
New York, New York
Founded
2014
SIOX Key Statistics
Market cap
22.02M
Price-Earnings ratio
—
Dividend yield
—
Average volume
879.20K
High today
$0.309
Low today
$0.2778
Open price
$0.2915
Volume
788.47K
52 Week high
$2.95
52 Week low
$0.2303
SIOX Earnings
-$0.35
-$0.23
-$0.12
$0.00
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Q3 FY22
Q4 FY22
Estimated
— per share
Actual
Expected Jun 9, Pre-Market